Journal article
Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region.
- Abstract:
- BACKGROUND: There is very little published data on the antibody response to the Vi capsular polysaccharide (Vi-CPS) of S. Typhi during naturally acquired typhoid fever in an endemic area. METHODOLOGY: An indirect ELISA, using tyraminated, purified Vi-CPS, was used to assay anti-Vi-CPS antibodies from typhoid fever cases and controls living in the Ho Chi Minh City and Mekong Delta region of Viet Nam. RESULTS: Antibody response to Vi-CPS is significantly higher in typhoid patients who have been ill for more than two weeks than those who are in the first two weeks of illness. The anti-Vi-CPS response is similar for adults and children. Anti-Vi-CPS antibodies can be detected in the sera of non-typhoid patients. The frequency with which this occurs increases with age, probably reflecting increased exposure to S. Typhi. CONCLUSIONS: Anti-Vi_CPS is elicited in persons infected with S. Typhi but only after a prolonged duration of illness. Vaccine trials have shown anti-Vi-CPS antibodies to be protective; thus early treatment of typhoid patients, i.e. in the first two week of illness before the Vi-CPS response is elicited, may inhibit the development of this protective immune response.
- Publication status:
- Published
Actions
Authors
- Journal:
- Journal of infection in developing countries More from this journal
- Volume:
- 2
- Issue:
- 4
- Pages:
- 308-312
- Publication date:
- 2008-01-01
- EISSN:
-
1972-2680
- ISSN:
-
2036-6590
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:186754
- UUID:
-
uuid:0ede310c-ab4a-4ac7-b953-93c78b09ea51
- Local pid:
-
pubs:186754
- Source identifiers:
-
186754
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2008
If you are the owner of this record, you can report an update to it here: Report update to this record